Recombinant Human Adenovirus Type 5 (H101) Intra-Tumor Therapy in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer: Genomic Profiling Relating to Clinical Efficacy

OBJECTIVE: Genomic profiles relating to H101 treatment-induced alterations are yet to be achieved. Here, we evaluated the impact of H101 via exome-sequencing approaches aiming to probe for potential biomarkers that are actionable in the treatment of persistent/recurrent/metastatic (P/R/M) cervical c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qiying, Zhang, Jing, Liu, Zi, Wang, Juan, Wang, Fei, Wang, Tao, Shi, Fan, Su, Jin, Zhao, Yalong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691960/
https://www.ncbi.nlm.nih.gov/pubmed/38046281
http://dx.doi.org/10.2147/DDDT.S429180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10691960/
https://www.ncbi.nlm.nih.gov/pubmed/38046281
http://dx.doi.org/10.2147/DDDT.S429180

Ejemplares similares